Bob,
Thanks for the interesting post. Here's some more info to add to what
you said, with some repeat and links.
Andre de Bruin was elected to Quidel's BOD in June 1997 while at the
same time he was the President and CEO of Somatogen. Jack Schuler was
on Somatogen's BOD. Jack Schuler and Lary Feinberg both increased
their positions in Quidel following Andre's election to Quidel's BOD.
Like you, I assume all three of these savvy businessmen and investors
know each other well, and their combined actions indicate to me a
strong endorsement of Quidel.
You pointed out: "If you have any doubt about the anticipated increase
in the use of POC testing, remember that Abbott just bought out
International Murex- so Abbott clearly sees the future of POC tests."
It's also worth noting that Jack Schuler was once with Abbott. One for
the money, two for the show . . . . .?
It seems to me Quidel's got some pretty knowledgeable directors and
investors on its side, and I'm confident they're not going to let
their investments fail.
Form SC 13D/A for QUIDEL CORP /DE/ filed on Sep 9 1997
edgar-online.com
". . . . . . In the last sixty days, 293,050 shares of Common Stock
were purchased by the Partnerships, the above-described managed
accounts and Mr. Schuler in open market transactions at an aggregate
cost of $1,363,277.00. Mr. Feinberg and Mr. Schuler reached an
agreement, on June 8, 1995, whereby the shares of Common Stock deemed
to be beneficially owned by Mr. Schuler would be voted together with
those deemed to be beneficially owned by Mr. Feinberg. . . . . . . . As
of the date hereof, the Reporting Persons together beneficially own
9.05% of Quidel's outstanding shares of Common Stock from 7.41%
beneficially owned as of July 27, 1995. . . . . "
Trade Date Number of Shares Price Per Share Value
8/19/97 2,500 $4.00 $ 10,000
8/20/97 10,000 4.1125 41,125
8/21/97 13,800 4.2894 59,194
8/22/97 11,500 4.1630 47,875
8/25/97 20,250 4.1867 84,781
8/26/97 25,000 4.375 109,375
8/27/97 40,000 4.5703 182,812
8/27/97 20,000 4.5625 91,250
8/28/97 60,000 4.875 292,500
8/29/97 10,000 4.8125 48,125
9/8/97 80,000 4.953 396,240
QUIDEL Board Elects Andre de Bruin to Its Board of Directors and Has
Appointed Him Vice Chairman
quidel.com
San Diego, CA, June 25, 1997 -- QUIDEL Corporation (NASDAQ:QDEL) today
announced that Mr. Andre de Bruin has been elected to its Board of
Directors and appointed Vice Chairman. Mr. de Bruin presently serves as
the Chairman, President and Chief Executive Officer of Somatogen, Inc.
Somatogen, Inc.
Mike |
